ASX-listed ResMed jumps on better-than-expected Q3 results
View all comments(0)
ASX-listed shares of ResMed RMD.AX jump 9.2% to A$36.31; set for steepest one-day pct gain since April 26, 2024
Stock hits highest since March 11; top gainer on benchmark index .AXJO
Healthcare tech co posts Q3 adjusted earnings per share of $2.37, marginally above analysts' estimate of $2.36
About 2.2 million shares traded, 1.3x the 30-day avg
RMD loses 2.8% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.